# US 2026/0083490 A1 · Method and device for ablating anatomical targets from within a blood vessel with in-procedure feedback

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083490 A1
- Document ID: US20260083490A1
- Status: Published application
- Kind: A1
- Application number: 19/337,355
- Filed: 2025-09-23
- Published: 2026-03-26
- Earliest claimed: 2024-09-24
- Applicants: Steer Medical Inc.
- Inventors: Dan Wittenberger; Domenic Santoianni; Darrin J. Kent; Michael J. Froncioni; Alan Clack
- Web page: https://patentgrep.com/patent/US20260083490A1

## CPC

- A61B 18/02: by cooling, e.g. cryogenic techniques
- A61B 90/37: {Surgical systems with images on a monitor during operation}
- A61M 25/1002: {characterised by balloon shape (A61M25/1006, A61M25/1009 take precedence)}
- A61M 25/1011: {Multiple balloon catheters}
- A61B 2018/0022: {Balloons}
- A61B 2018/00404: {Blood vessels other than those in or around the heart}
- A61B 2018/00434: {Neural system}
- A61B 2018/00577: {Ablation}
- A61B 2018/00791: {Temperature}
- A61B 2018/00797: {measured by multiple temperature sensors}
- A61B 2018/0212: {using an instrument inserted into a body lumen, e.g. catheter}
- A61B 2018/0262: {using a circulating cryogenic fluid}
- A61B 2090/378: {using ultrasound}
- A61M 2025/1052: {for temporarily occluding a vessel for isolating a sector}
- A61M 2025/1068: {having means for varying the length or diameter of the deployed balloon, this variations could be caused by excess pressure}
- A61M 2205/3327: Measuring
- A61M 2205/3331: Pressure; Flow
- A61M 2205/3368: Temperature
- A61M 2205/3375: Acoustical, e.g. ultrasonic, measuring means
- A61M 2205/3606: cooled
- A61M 2205/502: User interfaces, e.g. screens or keyboards
- A61M 2205/583: by visual feedback
- A61M 2210/12: Blood circulatory system
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A cryo-ablation system treats conditions associated with sympathetic nervous system hyperactivity using a catheter with a configurable heat transfer element that transitions from a flat delivery profile to deployed configurations including helical shapes. The system includes deployable temperature probes that directly measure tissue temperature at target locations inside or outside blood vessels. A computational control system processes temperature data from multiple sensors and deployable probes to calculate real-time lethal isotherm progression using heat transfer modeling algorithms. The system provides vessel occlusion during treatment and real-time feedback for treatment optimization. Methods include introducing the catheter into a renal artery, deploying the heat transfer element, occluding the vessel, deploying temperature probes to target locations within or outside the vessel, delivering cryogenic temperatures while monitoring probe temperatures, and terminating treatment based on computational analysis of temperature data to achieve target ablation depths.

## Claims

### Claim 1

A cryo-ablation system for treating resistant hypertension, comprising:
a cryo-ablation balloon configured to be placed within a blood vessel;
a deployable temperature probe outside the cryo-ablation catheter, to perform direct temperature measurement of tissue, at a known distance from the balloon.

### Claim 2 (depends on 1)

The cryo-ablation catheter of claim 1, including an occlusive cryo-ablation balloon configured to be placed within a blood vessel;
the occlusive cryo-ablation balloon being selectively transitionable from a substantially flat configuration to a cylindrical, conical, or helical shape for creating a continuous, circumferential, or helical elongated cryogenic treatment region of at least 5 mm in length;
a temperature monitoring system configured to measure temperatures at the temperature probe; and
a pressure sensing system to detect arterial occlusion distal to the cryo-ablation balloon.

### Claim 3 (depends on 1)

The cryo-ablation system of claim 1, wherein the catheter is an over-the-wire, rapid exchange, deflectable, or shapable configuration.

### Claim 4 (depends on 1)

The cryo-ablation system of claim 1, further comprising a shapeable structure including a metallic core wire encapsulated in an atraumatic polymer body, allowing manual shaping of the catheter at a desired angle or curvature.

### Claim 5 (depends on 1)

The cryo-ablation system of claim 1, further including a compliant occlusion balloon located on the catheter shaft proximal to the cryo-ablation balloon, wherein the occlusion balloon is configured to be manually inflated by the operator using a saline or contrast solution.

### Claim 6 (depends on 1)

The cryo-ablation system of claim 1, wherein the cryo-ablation balloon is configured to transition to a helical shape.

### Claim 7 (depends on 6)

The cryo-ablation system of claim 6, further comprising means to control the pitch, outer diameter, and length of the cryo-ablation balloon when deployed in the helical shape.

### Claim 8 (depends on 1)

The cryo-ablation system of claim 1, further comprising an ultrasound imaging system to visualize progression of tissue freezing, measure a diameter of frozen tissue volume, and calculate a position of a lethal isotherm to provide real-time feedback during a cryo-ablation procedure.

### Claim 9 (depends on 2)

The cryo-ablation system of claim 2, wherein the temperature monitoring system includes one or more temperature probes, at least one of which is situated outside the cryo-ablation balloon at a known distance to compute the distance of a lethal isotherm from the balloon surface.

### Claim 10 (depends on 9)

The cryo-ablation system of claim 9, wherein the temperature monitoring system is configured to display the distance of the lethal isotherm as a guide during the cryo-ablation procedure.

### Claim 11 (depends on 2)

The cryo-ablation system of claim 2, wherein the temperature monitoring system includes one or more deployable temperature probes that are advanceable through a vessel wall 1-10 mm.

### Claim 12 (depends on 1)

The cryo-ablation system of claim 1, wherein the cryo-ablation balloon has a deployed diameter sufficient to completely occlude the blood vessel.

### Claim 13

A method for treating resistant hypertension, comprising:
introducing a cryo-ablation catheter with an occlusive cryo-ablation balloon into a renal artery;
transitioning the cryo-ablation balloon from a flat configuration to a cylindrical, conical, or helical configuration within the renal artery to create a continuous cryogenic treatment region;
occluding the renal artery using the cryo-ablation balloon to reduce blood flow and increase the efficacy of the cryo-ablation;
achieving cryogenic temperatures to ablate renal sympathetic nerves adjacent to the renal artery;
measuring the temperature at a known distances outside the cryo-ablation balloon to determine tissue freezing; and
monitoring progression of tissue freezing at the known distances and adjusting cryo-ablation parameters based on real-time feedback from the temperature measurements.

### Claim 14 (depends on 13)

The method of claim 13, further comprising using ultrasound to monitor progression of tissue freezing and using a pressure sensing system to confirm arterial occlusion distal to the cryo-ablation balloon.

### Claim 15 (depends on 14)

The method of claim 14, further comprising manually shaping the cryo-ablation catheter to navigate and engage the distal branches of the renal artery.

### Claim 16 (depends on 14)

The method of claim 14, further comprising the step of inflating a compliant occlusion balloon proximal to the cryo-ablation balloon to achieve vessel occlusion if the cryo-ablation balloon does not fully occlude the renal artery.

### Claim 17 (depends on 14)

The method of claim 14, further comprising the step of computing a distance of a lethal isotherm from the cryo-ablation balloon and displaying this information to an operator for guiding duration and extent of cryo-ablation.

### Claim 18 (depends on 13)

The method of claim 13, wherein cryo-ablation is guided by an ultrasound imaging externally or within the renal artery to visualize the progression of tissue freezing and provide real-time feedback for the procedure.

### Claim 19 (depends on 13)

The method of claim 13, wherein the cryo-ablation is performed to treat medical conditions selected from the group consisting of resistant hypertension, heart failure, central sympathetic hyperactivity, metabolic syndrome, and obesity by cryo-ablating targets proximate to the renal artery.
